Inovio gets $71 mln from U.S. DoD for COVID-19 vaccine device

Inovio Pharmaceuticals Inc said on Tuesday it has received $71 million from the U.S. Department of Defense to scale up production of the company’s devices that are used to administer its experimental COVID-19 vaccine into the skin.